BODI vs GRPN
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Sep 09, 2026
BODI
GRPN
Investment Advisor Scores
GRPN
AI Analyst Insights
Detailed Metrics Comparison
| Metric | BODI | GRPN | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 7.657 | 21.1864 | BODI |
| PEG Ratio | 0 | 14.657 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -22.4% | -0.8% | GRPN |
| Earnings Growth | 0.0% | 109.2% | GRPN |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 53.5/100 | 59.5/100 | GRPN |
| Profit Margin | 5.7% | -25.3% | BODI |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
BODI
MarkdownPrice below a falling SMA50 (slope -14.7%), weak momentum, RSI 25
GRPN
NeutralMixed signals - no dominant trend phase, RSI 35
Fundamentals Snapshot
| Metric | BODI | GRPN |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 58.1 | 21.8 |
| Trailing P/E | 3.2 | — |
| Revenue (TTM) | — | — |
| Revenue Growth | -0.2% | 0.0% |
| Gross Margin | 0.7% | 0.9% |
| Operating Margin | 0.0% | 0.0% |
| EPS | 1.73 | -3.13 |
| Dividend Yield | — | — |